Conference - Boston, United States
Discovery on Target offers the opportunity to explore current "hot" targets, such as GPCRs, Kinases and Histone Deacetylases as well as to discover the "new kids on the block" which show a very promising future, such as Ubiquitin, Histone Methyltransferases and PI3K. In addition, new developments and strategies to target some of the most prevalent diseases are being presented in focused meetings such as Cancer Cell Metabolism, Diabetes Drug Discovery, Allosteric Modulators and Functional Genomic Screening Strategies.
Celebrating 10 years, Cambridge Healthtech Institute's "Discovery on Target" is a leading event, recognized and well attended by the pharmaceutical and biotech industry and academic institutions alike.
![dotLogo[1]](http://cdn2.hubspot.net/hub/45279/file-14302474-jpg/images/dotlogo[1].jpg?width=295&height=132&name=dotlogo[1].jpg)
(Courtesy of http://www.discoveryontarget.com/)
Mon, Oct 01, 2012 - Wed, Oct 03, 2012
Copley Marriott Hotel, Boston, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
